1. Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies Attenuate Arterial Wall Inflammation In Statin Intolerant Patients In Absence Of Crp Change. (August 2019) Authors: Hoogeveen, R.; Opstal, T.S.J.; Kaiser, Y.; Kroon, J.; Knol, R.J.J.; Bax, W.A.; Verberne, H.J.; Cornel, J.H.; Stroes, E.S. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The effect of low-dose colchicine on cause-specific mortality in the LoDoCo2 trial. (August 2021) Authors: Opstal, T.S.J.; Nidorf, S.M.; Fiolet, A.T.L.; Eikelboom, J.W.; Mosterd, A.; Thompson, P.L.; Budgeon, C.; Tijssen, J.G.P.; Bax, W.A.; Cornel, J.H. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗